• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, September 18, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Trojan Horse: How a killer fungus unleashes meningitis and brain infection

Bioengineer by Bioengineer
June 18, 2018
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Published today in The American Journal of Pathology, the study was led by a team from the Westmead Institute for Medical Research and the Marie Bashir Institute for Infectious Disease and Biosecurity of the University of Sydney.

Meningitis is an inflammation of the meninges, the three membranes that cover the brain and spinal cord. Meningitis can occur when fluid that bathes the brain and separates it from the meninges becomes infected.

Researchers identified a two-step invasion process mediated by the immune system, which, while being the body's primary defence against Cryptococcus infection, paradoxically promotes infection and meningitis.

The team observed the specific location where circulating white blood cells, known as monocytes, act as transport vehicles for cryptococci to cross from small blood vessels (post-capillary venues or PVCs) in and around the brain into the peri-vascular space outside these blood vessels.

They also observed cryptococci released from monocytes into this peri-vascular space then separately enter the brain, causing tumour-like lesions and the fluid surrounding the brain to cause meningitis.

Key findings

Lead researcher, Professor Tania Sorrell from the University of Sydney, said: "We have shown for the first time that the early immune response in neurocryptococcosis is comprised of white blood cells called monocytes, neutrophils and lymphocytes, recruited from the blood across the endothelial lining of PCVs into the adjacent peri-vascular space.

"We also show that blood-derived monocytes and, to a lesser extent, neutrophils, by acting as Trojan horses, are the major effectors of Cryptococcus neoformans invasion of the central nervous system, by the same route."

The discovery is an important first step for designing new treatments that could prevent and treat infection by the killer fungus, Professor Sorrell notes.

"Understanding this complex process is an important first step in designing new types of treatments that could complement the use of antifungal drugs.

Cryptococcus neoformans is a fungus that lives in the environment throughout the world, notes The Centers for Disease Control and Prevention. It is typically found in soil, on decaying wood, in tree hollows, or in bird droppings.

Cryptococcus neoformans is a common cause of meningitis that kills up to a third of patients even when treated appropriately.

Worldwide, an estimated 220,000 new cases of cryptococcal meningitis occur each year, resulting in 181,000 deaths.

People can become infected after breathing in the microscopic fungus, although most people who are exposed to the fungus never get sick from it.

Cryptococcus neoformans infections are rare in people who are otherwise healthy. Most cases occur in people who have weakened immune systems, particularly those who have advanced HIV/AIDS.

###

Media Contact

Dan Gaffney
[email protected]
61-481-004-782
@SydneyUni_Media

http://www.usyd.edu.au/

Share12Tweet7Share2ShareShareShare1

Related Posts

Repeated Head Trauma Drives Neuron Loss, Inflammation

September 18, 2025

Durable Perovskite Cells via Toughened Monolayers

September 18, 2025

Vitamins’ Role and Mechanisms in Obesity Control

September 18, 2025

Engineered Prime Editors Minimize Genomic Errors

September 18, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    155 shares
    Share 62 Tweet 39
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    117 shares
    Share 47 Tweet 29
  • Physicists Develop Visible Time Crystal for the First Time

    67 shares
    Share 27 Tweet 17
  • Tailored Gene-Editing Technology Emerges as a Promising Treatment for Fatal Pediatric Diseases

    48 shares
    Share 19 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Repeated Head Trauma Drives Neuron Loss, Inflammation

Bacterial Resistance to Heavy Metals and Chromium Reduction

Durable Perovskite Cells via Toughened Monolayers

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.